Search Results - "Clapp, Lucie"
-
1
The mechanistic basis of prostacyclin and its stable analogues in pulmonary arterial hypertension: Role of membrane versus nuclear receptors
Published in Prostaglandins & other lipid mediators (01-07-2015)“…Pulmonary arterial hypertension (PAH) is a progressive disease of distal pulmonary arteries in which patients suffer from elevated pulmonary arterial pressure,…”
Get full text
Journal Article -
2
Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: Treprostinil is a potent DP1 and EP2 agonist
Published in Biochemical pharmacology (01-07-2012)“…Differential activation of human prostanoid receptors expressed in cells: EC50 values for prostacyclin analogues treprostinil or iloprost in stimulating…”
Get full text
Journal Article -
3
International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1–4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions
Published in Pharmacological reviews (01-10-2020)“…Prostaglandins are derived from arachidonic acid metabolism through cyclooxygenase activities. Among prostaglandins (PGs), prostacyclin (PGI 2 ) and PGE 2 are…”
Get full text
Journal Article -
4
International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E 2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions
Published in Pharmacological reviews (01-10-2020)“…Prostaglandins are derived from arachidonic acid metabolism through cyclooxygenase activities. Among prostaglandins (PGs), prostacyclin (PGI ) and PGE are…”
Get full text
Journal Article -
5
Thomas (Tom) B. Bolton – a major force in smooth muscle research
Published in The Journal of physiology (01-08-2024)Get full text
Journal Article -
6
Prostanoid EP₂ Receptors Are Up-Regulated in Human Pulmonary Arterial Hypertension: A Key Anti-Proliferative Target for Treprostinil in Smooth Muscle Cells
Published in International journal of molecular sciences (12-08-2018)“…Prostacyclins are extensively used to treat pulmonary arterial hypertension (PAH), a life-threatening disease involving the progressive thickening of small…”
Get full text
Journal Article -
7
Vasopressin: Mechanisms of action on the vasculature in health and in septic shock
Published in Critical care medicine (01-01-2007)“…BACKGROUND:Vasopressin is essential for cardiovascular homeostasis, acting via the kidney to regulate water resorption, on the vasculature to regulate smooth…”
Get full text
Journal Article -
8
Exploring the enzymatic degradation of poly(glycerol adipate)
Published in European journal of pharmaceutics and biopharmaceutics (01-09-2019)“…[Display omitted] Poly(glycerol adipate) (PGA) is a biodegradable, biocompatible, polymer with a great deal of potential in the field of drug delivery. Active…”
Get full text
Journal Article -
9
Smooth Muscle Proliferation and Role of the Prostacyclin (IP) Receptor in Idiopathic Pulmonary Arterial Hypertension
Published in American journal of respiratory and critical care medicine (01-11-2010)“…Prostacyclin analogs, used to treat idiopathic pulmonary arterial hypertension (IPAH), are assumed to work through prostacyclin (IP) receptors linked to cyclic…”
Get full text
Journal Article -
10
Relative Recovery of Non-Alcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Rats
Published in Nutrients (28-12-2023)“…Consumption of a high-carbohydrate diet has a critical role in the induction of weight gain and obesity-related pathologies. This study tested the hypothesis…”
Get full text
Journal Article -
11
Prostacyclin mimetics inhibit DRP1-mediated pro-proliferative mitochondrial fragmentation in pulmonary arterial hypertension
Published in Vascular pharmacology (01-08-2023)“…Pulmonary arterial hypertension (PAH) is a rare cardiopulmonary disorder, involving the remodelling of the small pulmonary arteries. Underlying this…”
Get full text
Journal Article -
12
Altered cyclooxygenase-1 and enhanced thromboxane receptor activities underlie attenuated endothelial dilatory capacity of omental arteries in obesity
Published in Life sciences (1973) (15-12-2019)“…Obesity is a risk factor for endothelial dysfunction, the severity of which is likely to vary depending on extent and impact of adiposity on the vasculature…”
Get full text
Journal Article -
13
Bronchodilation induced by PGE2 is impaired in Group III pulmonary hypertension
Published in British journal of pharmacology (01-01-2020)“…Background and Purpose In patients with pulmonary hypertension (PH) associated with lung disease and/or hypoxia (Group III), decreased pulmonary vascular tone…”
Get full text
Journal Article -
14
Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature
Published in Clinical epigenetics (01-08-2022)“…Abstract Histone 3 lysine 27 (H3K27) demethylation constitutes an important epigenetic mechanism of gene activation. It is mediated by the Jumonji C…”
Get full text
Journal Article -
15
Pharmacology of the single isomer, esuberaprost (beraprost-314d) on pulmonary vascular tone, IP receptors and human smooth muscle proliferation in pulmonary hypertension
Published in Biochemical pharmacology (01-08-2019)“…[Display omitted] Beraprost is a prostacyclin analogue and IP receptor agonist which is approved to treat pulmonary arterial hypertension (PAH) in Asia. The…”
Get full text
Journal Article -
16
Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension
Published in Circulation (New York, N.Y.) (05-08-2014)“…BACKGROUND—Pulmonary hypertension (PH) is a life-threatening disorder characterized by increased pulmonary artery pressure, remodeling of the pulmonary…”
Get full text
Journal Article -
17
The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels
Published in Frontiers in pharmacology (29-06-2021)“…Pulmonary arterial hypertension (PAH) is an aggressive vascular remodeling disease that carries a high morbidity and mortality rate. Treprostinil (Remodulin)…”
Get full text
Journal Article -
18
Bronchodilation induced by PGE 2 is impaired in Group III pulmonary hypertension
Published in British journal of pharmacology (01-01-2020)“…In patients with pulmonary hypertension (PH) associated with lung disease and/or hypoxia (Group III), decreased pulmonary vascular tone and tissue hypoxia is…”
Get full text
Journal Article -
19
Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI₂ analogues in rat tail artery: Evidence for Gᵢ/ₒ modulation via EP₃ receptors
Published in European journal of pharmacology (11-03-2011)“…Prostanoid IP receptors coupled to Gs are thought to be the primary target for prostacyclin (PGI₂) analogues. However, these agents also activate prostanoid…”
Get full text
Journal Article -
20
Interaction between PGI2 and ET-1 pathways in vascular smooth muscle from Group-III pulmonary hypertension patients
Published in Prostaglandins & other lipid mediators (01-02-2020)“…•The ratio of ETA/ETB receptor expression is increased in pulmonary artery derived from Pulmonary Hypertension (PH) Group-III patients.•ETB receptor antagonist…”
Get full text
Journal Article